Back to Locations

Horizon Oncology Center

1345 Unity Place, Suite 345 - Lafayette, IN 47905

For information about clinical trials being conducted in Lafayette, IN, please contact Linda Vaders at 765.446.5111.


Wael Harb, MD (Principal Investigator)

Trials at this Location:


Disease: Banking / Biorepository
A Biological Sample Collection Protocol of Patients with and without Metastatic Solid Organ Malignancies - BNK09-138
Status: Open to Accrual 10-06-2009; 96 of 200 accrued.
More Details
Disease: Breast
Predicting Response and Toxicity in Patients Receiving Lonafarnib for Breast Cancer: A Multicenter Genomic, Proteomic and Pharmacogenomic - BRE-126
Status: Open to Accrual at Limited Institutions Only - Open to Accrual 06-26-2009; 15 of 44 accrued.
More Details
Disease: Breast
PARP Inhibition after Preoperative Chemotherapy in Patients with Triple Negative Breast Cancer or ER/PR +, HER2 negative with known BRCA1/2 Mutations - BRE09-146
Status: Opened 2/22/2010; 5 of 135 Accrued
More Details
Disease: Breast
Predicting Response and Toxicity in Patients Receiving Chemotherapy for Breast Cancer: A Multicenter Genomic, Proteomic and Pharmacogenomic Correlative Study - DoD COE-01
Status: Open to Accrual at Limited Institutions Only - Open to Accrual 09-27-2005 - 73 of 133 Patients Accrued
More Details
Disease: Breast
Predicting Response and Toxicity in Patients Receiving Lonafarnib for Breast Cancer: A Multicenter Genomic, Proteomic and Pharmacogenomic Correlative - DoD COE-03 (BRE-126)
Status: Open to Accrual at Limited Institutions Only - Open to Accrual 06-26-2009; 15 of 44 accrued.
More Details
Disease: Colorectal
A Phase I / Randomized Phase II Study of Second Line Therapy with Irinotecan and Cetuximab with or without RAD001 (an mTOR Inhibitor) for Patients with Metastatic Colorectal Cancer - GI05-102
Status: Suspended to Accrual to control accrual to cohort; Originally opened to Accrual 08-02-2007 - 14 of 119 Patients Accrued
More Details
Disease: Lung
A Randomized Double Blind Phase II Trial of Cisplatin plus Etoposide with/without Concurrent ZD6474 in Patients with Previously Untreated Extensive Stage Small Cell Lung Cancer - LUN06-113
Status: Open to Accrual - 01-23-2008 - 32 of 74 Patients Accrued
More Details
Disease: Lung
A Phase II study of Concurrent Pemetrexed and Radiation for Poor-Risk Stage III Non-Small Cell Lung Cancer - LUN08-129
Status: Open to Accrual - 7 of 44 Patients Accrued
More Details
Disease: Lung
A Phase 1b/ 2 Study of AMG 479 in Combination with Paclitaxel and Carboplatin for the First-Line Treatment of Advanced Squamous Non-Small Cell Lung Cancer - LUN08-137
Status: Permenately suspended to further accrual effective 7/27/2010; 12 patients accrued
More Details